Médecine personnalisée et cancer: organiser et financer l'accès à l'innovation. IGR press, 2013. ,
Pheochromocytoma: State-of-the-Art and Future Prospects, Endocrine Reviews, vol.24, issue.4, pp.539-53, 2003. ,
DOI : 10.1210/er.2002-0013
Adrenal tumours : Introduction. RA DeLellis PU Heitz C Eng WHO Classifi Cation Tumours-Pathol Genet-Tumours Endocr Organs, 2004. ,
Phéochromocytomes et Paragangliomes: aspects récents. Actual Néphrologiques Jean Hambg Hôp Necker, 2011. ,
Phéochromocytome-paragangliome héréditaire. Orphanet, 2011. ,
mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma, International Journal of Cancer, vol.118, issue.Suppl 2, pp.2711-2731, 2014. ,
DOI : 10.1002/ijc.28913
Guide Affection de longue durée -Cancer du rein de l'adulte [Internet], 2010. ,
Germline SDHB Mutations and Familial Renal Cell Carcinoma, JNCI Journal of the National Cancer Institute, vol.100, issue.17, pp.1260-1262, 2008. ,
DOI : 10.1093/jnci/djn254
The oxidation of pyruvate in pigeon breast muscle, Biochemical Journal, vol.34, issue.3, pp.442-59, 1940. ,
DOI : 10.1042/bj0340442
Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer, Nature Genetics, vol.30, issue.4, pp.406-416, 2002. ,
DOI : 10.1038/ng849
The reaction of ascites tumor cells to oxygen under high pressure], Arch Für Geschwulstforsch, vol.6, issue.1, pp.7-11, 1953. ,
Mitochondrial tumour suppressors: a genetic and biochemical update, Nature Reviews Cancer, vol.284, issue.11, pp.857-66, 2005. ,
DOI : 10.1074/jbc.M204958200
Metabolomic Profiling from Formalin-Fixed, Paraffin-Embedded Tumor Tissue Using Targeted LC/MS/MS: Application in Sarcoma, PLoS ONE, vol.6, issue.10, p.25357, 2011. ,
DOI : 10.1371/journal.pone.0025357.s005
NMR and LC/MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosis, International Journal of Cancer, vol.54, issue.3, 2014. ,
DOI : 10.1002/ijc.28706
Krebs Cycle Metabolite Profiling for Identification and Stratification of Pheochromocytomas/Paragangliomas due to Succinate Dehydrogenase Deficiency, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.10, pp.3903-3914, 2014. ,
DOI : 10.1210/jc.2014-2151
Derivatization of the tricarboxylic acid intermediates with O-benzylhydroxylamine for liquid chromatography???tandem mass spectrometry detection, Analytical Biochemistry, vol.465, pp.134-181, 2014. ,
DOI : 10.1016/j.ab.2014.07.027
Measurement of Urinary D- and L-2-Hydroxyglutarate Enantiomers by Stable-Isotope-Dilution Liquid Chromatography-Tandem Mass Spectrometry after Derivatization with Diacetyl-L-Tartaric Anhydride, Clinical Chemistry, vol.50, issue.8, pp.1391-1396, 2004. ,
DOI : 10.1373/clinchem.2004.033399
Serum 2- hydroxyglutarate levels predict isocitrate dehydrogenase mutations and clinical outcome in acute myeloid leukemia. Blood, Jun, vol.13121, issue.24, pp.4917-4941, 2013. ,
LC-MS/MS method after derivation for the determination of L and D isomers of 2- hydroxyglutaric acid in biological fluids, suitable for clinical applications in IDH mutated cancers, À Par J Chromatogr B, 2015. ,
Validation of analytical procedures: Text and Methodology, Q2 R1 [Internet], 2005. ,
Guideline on bioanalytical method validation Available from, 2011. ,
UPLC-ESI-QTOF/MS and multivariate data analysis for blood plasma and serum metabolomics: Effect of experimental artefacts and anticoagulant, Analytica Chimica Acta, vol.768, pp.118-146 ,
DOI : 10.1016/j.aca.2013.01.015
Samples:From the Patient to the Laboratory: The impact of preanalytical variables on the quality of laboratory results, 2008. ,
Hereditary paraganglioma targets diverse paraganglia, Journal of Medical Genetics, vol.39, issue.9, pp.617-639, 2002. ,
DOI : 10.1136/jmg.39.9.617
Factors Associated with Perioperative Morbidity and Mortality in Patients with Pheochromocytoma: Analysis of 165 Operations at a Single Center, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.4, pp.1480-1486, 2001. ,
DOI : 10.1210/jc.86.4.1480
The Succinate Dehydrogenase Genetic Testing in a Large Prospective Series of Patients with Paragangliomas, The Journal of Clinical Endocrinology & Metabolism, vol.94, issue.8, pp.2817-2844, 2009. ,
DOI : 10.1210/jc.2008-2504
Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas, The Journal of Clinical Endocrinology & Metabolism, vol.92, issue.10, 2007. ,
DOI : 10.1210/jc.2007-0709
Pheochromocytomas: The (pseudo)-hypoxia hypothesis, Best Practice & Research Clinical Endocrinology & Metabolism, vol.24, issue.6, pp.957-68, 2010. ,
DOI : 10.1016/j.beem.2010.10.004
A novel TMEM127 mutation in a patient with familial bilateral pheochromocytoma, European Journal of Endocrinology, vol.164, issue.1 ,
DOI : 10.1530/EJE-10-0758
The estimated incidence of gastrointestinal stromal tumors in France. Results of PROGIST study conducted among pathologists, Bull Cancer, vol.97, issue.3, pp.16-22, 2010. ,
??pid??miologie des tumeurs c??r??brales primitives, Revue Neurologique, vol.165, issue.8-9, pp.83-89, 2010. ,
DOI : 10.1016/j.neurol.2009.04.002
Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) ??? A review, The International Journal of Biochemistry & Cell Biology, vol.53, pp.514-523 ,
DOI : 10.1016/j.biocel.2014.05.033
Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas, The American Journal of Surgical Pathology, vol.38, issue.4, pp.560-566, 2014. ,
DOI : 10.1097/PAS.0000000000000149